Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Charcot Marie Tooth Disease (CMT): early-phase trial registry
2 of 3 indexed Charcot Marie Tooth Disease (CMT) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Charcot Marie Tooth Disease (CMT): 3 US clinical trials tracked, 2 recruiting.
Charcot Marie Tooth Disease (CMT) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Bopha Chrea, running 1 of these trials.
Enrollment posture brief
Registry condition charcot-marie-tooth-disease-cmt
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Charcot Marie Tooth Disease (CMT) lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Charcot Marie Tooth Disease (CMT) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Charcot Marie Tooth Disease (CMT) is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
CMT Gait, Mobility, Balance - AOFAS Grant
Bopha Chrea
NCT07188415
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
University of Missouri-Columbia
NCT07478172
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
Vanda Pharmaceuticals
NCT07223632
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Charcot Marie Tooth Disease (CMT) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Charcot Marie Tooth Disease (CMT) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Charcot Marie Tooth Disease (CMT) page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Charcot Marie Tooth Disease (CMT) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bopha Chrea sponsors the most Charcot Marie Tooth Disease (CMT) trials on record, review their full trial history before evaluating a specific study. See Bopha Chrea's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Charcot Marie Tooth Disease (CMT) condition card totals 3 registered trials; most-linked intervention VCA-894A; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.